Guangdong Zhongsheng Pharmaceutical Co., Ltd.

SZSE:002317.SZ

17.26 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 2,610.552,676.1522,429.0951,895.8242,531.5162,361.5061,964.2351,692.4861,577.7371,308.5171,090.028886.433750.644640.715551.603484.305404.403326.897
Cost of Revenue 1,080.875940.486806.557657.142917.452903.944811.143516.199573.144517.413451.869337.673272.388234.754211.684227.067214.675189.973
Gross Profit 1,529.6751,735.6651,622.5381,238.6821,614.0641,457.5621,153.0921,176.2871,004.592791.104638.159548.76478.255405.961339.919257.238189.728136.924
Gross Profit Ratio 0.5860.6490.6680.6530.6380.6170.5870.6950.6370.6050.5850.6190.6370.6340.6160.5310.4690.419
Reseach & Development Expenses 127.369156.591136.726113.623132.58384.29167.51674.15867.50967.05552.10430.9931.92927.567011.7538.3455.333
General & Administrative Expenses 48.03441.56257.98750.50856.51747.21634.96724.00230.26320.47615.39211.59712.569.78637.0510.3349.2447.538
Selling & Marketing Expenses 889.8971,000.081940.736722.291853.752749.817593.679589.613527.609434.844358.205300.642255.435225.92185.206135.857100.53276.101
SG&A 937.9311,041.644998.723772.799910.269797.033628.646613.615557.872455.32373.598312.239267.995235.706222.256146.192109.77683.639
Other Expenses -15.074142.68186.7171.38188.995-0.987-1.97725.4949.9757.4679.28612.759-10.642-9.6417.4355.162-4.2180.269
Operating Expenses 1,177.7951,340.9151,222.16957.8041,131.848940.328692.337747.991684.88567.741456.862373.504326.753279.985227.309169.309128.17597.702
Operating Income 298.731374.263443.323388.009518.915500.952493.702458.302332.719240.805209.303200.245168.776144.23108.66380.32156.64936.401
Operating Income Ratio 0.1140.140.1830.2050.2050.2120.2510.2710.2110.1840.1920.2260.2250.2250.1970.1660.140.111
Total Other Income Expenses Net -62.553-5.96-133.845-733.281-140.037-17.2730.9755.09522.1924.90336.68337.55123.6527.1772.135-2.475-9.692-2.746
Income Before Tax 283.657368.302309.478-345.272378.877499.965491.725483.391341.903248.265217.98212.807175.152153.152114.74685.45351.86136.476
Income Before Tax Ratio 0.1090.1380.127-0.1820.150.2120.250.2860.2170.190.20.240.2330.2390.2080.1760.1280.112
Income Tax Expense 33.75652.95434.80889.15759.10369.46468.72362.90446.2732.28430.60731.29524.61521.64214.39111.0696.7231.883
Net Income 263.273322.05277.631-434.429317.729435.648420.121414.369296.715224.562187.702181.512150.537131.51100.35574.38442.26631.882
Net Income Ratio 0.1010.120.114-0.2290.1260.1840.2140.2450.1880.1720.1720.2050.2010.2050.1820.1540.1050.098
EPS 0.320.40.35-0.540.40.540.520.550.410.310.260.250.210.180.190.140.0780.11
EPS Diluted 0.320.40.35-0.540.40.530.520.540.40.310.260.250.210.180.190.140.0780.11
EBITDA 511.616540.572539.339486.68617.206630.029556.981562.846414.852313.014251.08241.582198.386169.593127.671105.87368.5949.746
EBITDA Ratio 0.1960.2020.2220.2570.2440.2670.2840.3330.2630.2390.230.2730.2640.2650.2310.2190.170.152